{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816481,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103046","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:50:16Z","timestamp":1790207416000},"page":"103046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FJX1 drives FOLFOX resistance via PPAR\u03b3-mediated EMT and serves as a prognostic biomarker in colorectal cancer"],"prefix":"10.1016","volume":"73","author":[{"given":"Mao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongguo","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.103046_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2026.103046_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103046_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101276","article-title":"Experimental study of tumor-associated macrophage-derived spp1 inhibit cd8(+) t cells to promote colorectal cancer progression","volume":"73","author":"Hao","year":"2026","journal-title":"Neoplasia (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.tranon.2026.103046_bib0004","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.tranon.2026.103046_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103046_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1873649","article-title":"Editorial: new tumor immune checkpoints and their applications in tumor immunotherapy","volume":"13","author":"Zhang","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tranon.2026.103046_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101267","article-title":"Loxl2? Cancer-associated fibroblasts shape wnt signaling to drive chemoresistance and poor outcomes in colorectal cancer: insights from multi-omics and epidemiological analyses","volume":"72","author":"Xu","year":"2026","journal-title":"Neoplasia (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.tranon.2026.103046_bib0008","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated tcga pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103046_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med."},{"issue":"12","key":"10.1016\/j.tranon.2026.103046_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114127","article-title":"Ccl19-armed recombinant influenza virus inhibited colorectal cancer growth by remodeling tumor microenvironment","volume":"28","author":"Ou","year":"2025","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.tranon.2026.103046_bib0011","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage ii or iii colon cancer in the mosaic trial","volume":"27","author":"Andre","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103046_bib0012","first-page":"319","article-title":"Curcumin targets folfox-surviving colon cancer cells via inhibition of egfrs and igf-1r","volume":"30","author":"Patel","year":"2010","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.tranon.2026.103046_bib0013","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.soc.2017.05.007","article-title":"An update on randomized clinical trials in metastatic colorectal carcinoma","volume":"26","author":"Ikoma","year":"2017","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.tranon.2026.103046_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"Folfiri followed by folfox6 or the reverse sequence in advanced colorectal cancer: a randomized gercor study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J. clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.tranon.2026.103046_bib0015","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103046_bib0016","article-title":"Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: a mini-review","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.tranon.2026.103046_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/humu\/9567214","article-title":"Metabolic reprogramming in colorectal cancer: the impact of fatty acid metabolism","volume":"2025","author":"Zhuang","year":"2025","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.tranon.2026.103046_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","article-title":"Crosstalk between pi3k\/akt and wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status","volume":"23","author":"Fleming-De-Moraes","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.tranon.2026.103046_bib0019","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0925-4773(98)00218-4","article-title":"Fjx1, the murine homologue of the drosophila four-jointed gene, codes for a putative secreted protein expressed in restricted domains of the developing and adult brain","volume":"80","author":"Ashery-Padan","year":"1999","journal-title":"Mech. Develop."},{"issue":"6","key":"10.1016\/j.tranon.2026.103046_bib0020","first-page":"975","article-title":"Fjx1 overexpression is associated with poor prognosis and promotes gastric cancer proliferation via the pi3k\/akt signaling pathway","volume":"43","author":"Zhang","year":"2023","journal-title":"Nan Fang Yi Ke Xue Xue Bao\u202f=\u202fJ. South. Med. Univ."},{"issue":"7","key":"10.1016\/j.tranon.2026.103046_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069660","article-title":"Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma","volume":"8","author":"Al-Greene","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2026.103046_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3857853","article-title":"An oncogenic role for four-jointed box 1 (fjx1) in nasopharyngeal carcinoma","volume":"2019","author":"Chai","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.tranon.2026.103046_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153835","article-title":"Mir-532-3p suppresses cell proliferation, migration and invasion of colon adenocarcinoma via targeting fjx1","volume":"232","author":"Cheng","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.tranon.2026.103046_bib0024","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s12094-022-02852-5","article-title":"Fjx1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer","volume":"24","author":"Liu","year":"2022","journal-title":"Clin. Transl. Oncol.: Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.tranon.2026.103046_bib0025","article-title":"Comprehensive analysis of the prognosis and immune effect of the oncogenic protein four jointed box 1","volume":"13","author":"Huang","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103046_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","article-title":"Measurement of MRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples","volume":"131","author":"Wagner","year":"2012","journal-title":"Theory Biosci.\u202f=\u202fTheor. Biowiss."},{"issue":"7407","key":"10.1016\/j.tranon.2026.103046_bib0027","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103046_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3850674","article-title":"Identification of six genes as diagnostic markers for colorectal cancer detection by integrating multiple expression profiles","volume":"2022","author":"Wu","year":"2022","journal-title":"J. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2026.103046_bib0029","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.bpj.2011.04.047","article-title":"Orientation and polarity in collectively migrating cell structures: statics and dynamics","volume":"100","author":"Reffay","year":"2011","journal-title":"Biophys. J."},{"issue":"8","key":"10.1016\/j.tranon.2026.103046_bib0030","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.18632\/oncotarget.14638","article-title":"Building personalized treatment plans for early-stage colorectal cancer patients","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.tranon.2026.103046_bib0031","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/path.2487","article-title":"The atm tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma","volume":"217","author":"Bose","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.tranon.2026.103046_bib0032","article-title":"Editorial: exploring key pathways in the progression of gastrointestinal diseases based on metabolic reprogramming and developing drugs targeting metabolism","volume":"17","author":"Jia","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103046_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.960954","article-title":"Multi-omics analysis of the tumor microenvironment in liver metastasis of colorectal cancer identified fjx1 as a novel biomarker","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.tranon.2026.103046_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13062-025-00654-7","article-title":"A multi-omics exploration of pparg activation in colon cancer: kinases featuring a ppre sequence within regulatory regions","volume":"20","author":"Saha","year":"2025","journal-title":"Biol. Direct."},{"issue":"4","key":"10.1016\/j.tranon.2026.103046_bib0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bjp.0703628","article-title":"Bisphenol a diglycidyl ether (badge) is a ppargamma agonist in an ecv304 cell line","volume":"131","author":"Bishop-Bailey","year":"2000","journal-title":"Brit. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.tranon.2026.103046_bib0036","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/bi0159581","article-title":"Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by gw9662","volume":"41","author":"Leesnitzer","year":"2002","journal-title":"Biochem.-US"},{"key":"10.1016\/j.tranon.2026.103046_bib0037","doi-asserted-by":"crossref","unstructured":"Z.T. Laughlin, L. Arifova, P. Munoz-Tello, et al, Structural basis of ppar\u03b3-mediated transcriptional repression by the covalent inverse agonist fx-909, bioRxiv: the preprint server for biology 2025) 2025, doi:10.1101\/2025.05.04.651770.","DOI":"10.1101\/2025.05.04.651770"},{"issue":"1","key":"10.1016\/j.tranon.2026.103046_bib0038","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12672-024-01163-1","article-title":"Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions","volume":"15","author":"Yan","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103046_bib0039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-025-02313-2","article-title":"Regulatory role of PPAR in colorectal cancer","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:28:49Z","timestamp":1791703729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S1936523326003827"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103046","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FJX1 drives FOLFOX resistance via PPAR\u03b3-mediated EMT and serves as a prognostic biomarker in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103046"}}